Skip to main content
Premium Trial:

Request an Annual Quote

Roche, RBM to Collaborate on Companion Dx

NEW YORK (GenomeWeb News) - Rules-Based Medicine today said that its Psynova Neurotech subsidiary will collaborate with Roche on the development and commercialization of diagnostic assays to aid in the development of new schizophrenia treatments.

Under the exclusive research and licensing deal, Roche will contract Psynova to identify protein biomarkers that have utility in prognosis of disease progression and predicting or monitoring the efficacy and safety of a compound from Roche's central nervous system pipeline. Psynova said that it will use its schizophrenia biomarker panels, CNS disease database, and access to RBM's DiscoveryMAP technology to identify a specific biomarker signature that could serve as a companion diagnostic.

Companion diagnostics will be developed either by Psynova and RBM or independently by Roche, which would result in milestone and royalty payments to Psynova.

Financial and further terms of the collaboration were not disclosed.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.